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ABSTRACT
This paper describes the clinical features of a series of patients admitted to the specialist HIV/AIDS unit 
(Jagori) of the Dhaka Hospital, ICDDR,B (International Centre for Diarrhoeal Disease Research, Ban-
gladesh) during May 2008–February 2010. Data were collected from a review of documents and electronic 
case-records and collation of laboratory results with respect to CD4 counts. One hundred and nine patients 
were admitted during this period. Their mean age was 33.4 years, and 62% were male. On admission, the 
mean CD4 count±standard deviation (SD) was 244±245 (range 2-1,549). The death rate was 12%. The 
patients were classified as World Health Organization clinical stage 1: 23%, stage 2: 30%, stage 3: 23%, 
and stage 4: 24% during the admission. The commonest diagnosis recorded was tuberculosis (TB) (23%), 
which was also the commonest cause of death (38%). Even for those clinicians with limited experience of 
managing AIDS cases, the commonest problem encountered in this patient group was TB, reflecting the 
continued high burden of TB on health services in Bangladesh. Additional challenges to managing TB/HIV 
co-infection include atypical presentations in HIV-infected persons and the complex drug interaction with 
antiretroviral therapy.
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INTRODUCTION
Although the prevalence of HIV remains very low 
(<0.1%) in the general population and low (<1%) in 
most at-risk populations (MARPs) (1,2), by the end 
of 2009, the Ministry of Health and Family Welfare 
(MoHFW) in Bangladesh had confirmed 1,745 HIV 
cases, 619 of which had developed acquired immu-
nodeficiency syndrome (AIDS), and 204 had died 
(3). The national AIDS/STD Programme of the Mo-
HFW estimated that 7,500 people in Bangladesh 
are living with HIV (3). 
In the developed world, the management of HIV/
AIDS has been transformed by the widespread 
availability of antiretrovirals and management of 
opportunistic infections. In Bangladesh, a limited 
range of (first-line) antiretrovirals has been avail-
able since 2003 (3). A specialist inpatient unit (Jag-
ori) for the management and treatment of HIV-posi- 
tive individuals was launched in May 2008 in the 
Dhaka Hospital of ICDDR,B. Managing HIV/AIDS 
is a relatively new field in Bangladesh, and little in-
formation exists regarding the clinical presentation 
of AIDS in the country. This paper reviews the clini-
cal profile of patients admitted to the Jagori Unit 
during May 2008–February 2010. 
MATERIALS AND METHODS
This is a retrospective review of all the admissions to 
the Jagori Unit of the Dhaka Hospital of ICDDR,B 
during May 2008–February 2010.
In Bangladesh, a number of peer non-governmen-
tal organizations (NGOs) provide care and support 
to people living with HIV (PLHIV). The vast ma-
jority of the admissions to the ward are referred 
from these NGOs and so are previously known 
to be HIV-positive. Admission data for the May 
2008–February 2010 period were gathered from 
an admission notebook kept on the ward, and the 
paper notes were reviewed for clinical and micro-
biological data. Since February 2009, the Dhaka Matin N et al.
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Hospital moved to an electronic patient-record sys-
tem (EPR), and admission data were gathered from 
this computerized system. All microbiological and 
virological data were extracted either from the EPR 
or from the chart review. Diagnosis data and World 
Health Organization (WHO) clinical staging data 
were extracted from the clinical notes.
Mycobacterium tuberculosis-associated infection (TB) 
was diagnosed using the following criteria: pul-
monary TB was diagnosed by appropriate clinical 
symptoms and/or a chest radiograph compatible 
with TB and a positive sputum smear for acid fast 
bacilli or a positive sputum culture report. Dissemi-
nated TB was classified as clinical features of TB and 
involvement of at least two organs, with bacterio-
logical or histological evidence of TB. TB menin-
gitis was diagnosed by bacteriological evidence on 
cerebrospinal fluid examination or after exclusion 
of other causes of meningitis and/or with radiologi-
cal evidence (computerized tomography brain im-
aging—CT) of TB meningitis and clinical improve-
ment after the commencement of anti-tuberculosis 
therapy. Malignancies were confirmed histolog-
ically. Oesophageal candidiasis was diagnosed by 
endoscopic examination or clinical evidence of 
oral candidiasis with swallowing difficulties which 
improved on antifungal therapy. Cytomegalovirus 
(CMV) retinitis was diagnosed on fundoscopic ex-
amination; CMV colitis was diagnosed by sugges-
tive clinical symptoms and colonoscopic evidence 
of ulceration which resolved on Ganciclovir thera-
py. The diagnosis of disseminated fungal disease 
was made on histological examination of biopsy 
samples. The diagnosis of sepsis was made for pa-
tients who presented with the clinical features of 
septicaemia, which was either confirmed bacte-
riologically and/or responded to antibacterial treat-
ment.
All antiretroviral prescribing was carried out by the 
patient’s affiliated NGO; so, limited data were avail-
able on regime switches and reasons. Data were 
extracted for drug regime on admission, new diag-
noses of HIV during admission, and the reasons for 
carrying out an HIV test.
RESULTS
One hundred and nine patients were admitted to 
the ward during May 2008–February 2010. Their age 
ranged from 1.5 years to 65 years (mean 33.4 years 
and median 35 years). Sixty-eight (62%) patients 
were male, and 41 (38%) were female. The adult 
patients were aged 18-65 years (mean 35.3 years, 
median 36 years, and mode 40 years). 
Data regarding the history of previous risks of HIV 
acquisition were collected from the medical notes. 
Heterosexual transmission was recorded in 87 
(80%) of the cases. Forty (37%) patients reported 
a history of external migration (living abroad for 
employment purposes) in the past. This group of 
patients comprised exclusively males. Thirty-two 
(29%) had HIV-positive spouses, of whom most 
(97%) were exclusively female. Ten (9%) patients 
were admitted previously, who reported buying sex 
from sex workers. Five (5%) patients gave a history 
of previous commercial sex work. After heterosexu-
al transmission, a history of injecting drug-use was 
recorded in 11 (10%) cases and possible vertical 
transmission (mother also found to be positive) in 
6 (5.5%) cases. Two (1.8%) cases had a history of 
bisexual contact or being MSM (men who have 
sex with men). In two (1.8%) cases, no risk-factor 
data were available, and one (0.9%) was believed 
to be transfusion-associated. Seven patients (6.4%) 
were children (defined as age below 18 years); their 
age ranged from 1.5 years to nine years (Table 2). 
The mode of transmission for six of the children 
was believed to be vertical; one child had received 
multiple blood transfusions from an HIV-infected 
donor and had an HIV-negative mother.
During the admission/upon discharge, the patients 
were classified according to clinical stages of the 
WHO (4) as follows: clinical stage 1: 25 (23%) pa-
tients; clinical stage 2: 33 (30%) patients; clinical 
stage 3: 25 (23%) patients; and clinical stage 4: 26 
(24%) patients. 
CD4 count data were available for 102 (94%) of the 
patients (Table 1). CD4 counts were measured upon 
admission. The mean CD4 count was 244±245 
[standard deviation (SD)] (range 2-1,549 and me-
dian count 170). Of the 109 admitted patients, 13 
(12%) died in hospital. Five (38%) deaths occurred 
due to TB (3 cases of pulmonary TB, one case of 
disseminated TB, one case of TB meningitis). Four 
(31%) deaths were attributed to overwhelming sep-
sis, one (7.7%) case was due to CMV disease, and 
one (7.7%) case due to malignancy. Two (15%) 
cases had no attributable cause. Of the 13 deaths, 
eight had a CD4 count of <50 cells/µL.
Among all the patients, the most common diag-
nosis recorded was TB with 25 cases (23%) (Table 
Table 1.  CD4 count results (specimens were 
taken on admission)
CD4 cells/µL
No. of 
patients
(n=102)
CD4 counts 
for  in-
hospital 
deaths (n=13)
No. % No. %
<50  24 24 8  62
51-200  32 31 2 15
201-350 19 19 1 8
>351 27 26 2 15Matin N et al. Clinical profile of HIV/AIDS-infected patients in Bangladesh
JHPN 16
2). The second commonest diagnosis was pulmo-
nary infection, with 12 (11%) cases recorded.  Some 
patients were recorded as having more than one 
diagnosis. Eight women were admitted with preg-
nancy-related conditions, i.e. shortly after caesar-
ean section for postnatal care. 
A range of diagnoses not related with AIDS was 
recorded (Table 3). The commonest diagnosis re-
corded was diabetes mellitus (8.2%), followed by 
hypertension (3.7%).
In 100 (92%) cases, the patients were known to be 
HIV-positive before admission to hospital. Nine 
Table 3. Diagnoses not related with AIDS (pat- 
ients may have had more than one 
diagnosis)
Diagnosis
Cases
No. %
Diabetes mellitus 9 8.2
Hypertension 4 3.7
Urinary tract infection/
renal colic 3 2.8
Physical assault, e.g. 
street-fight 3 2.8
Haemoglobinopathy 2 1.8
Psychological distress 2 1.8
Surgical, e.g. appendicitis  2 1.8
Ischaemic heart disease 1 0.9
Cerebral stroke 1 0.9
Hypothyroidism 1 0.9
patients were newly diagnosed to be HIV-positive. 
They were inpatients in our own hospital (n=6) 
or another healthcare facility (n=3), with another 
medical condition. The conditions that led to car-
rying out an HIV test are outlined here. One case 
was diagnosed with Kaposi’s sarcoma, and in three 
cases, there was a diagnosis of TB in conjunction 
with a history of injecting drug-use in one case, an 
associated history of professional sex work in one 
case, and a history of buying sex from sex worker 
in one case. In three other cases, TB was diagnosed, 
and no additional indication for testing was re-
corded. In two patients, the test was carried out due 
to a long history of loss of weight and intractable 
diarrhoea for which no pathogen had been iden-
tified. Forty-five (41%) patients were on antiret-
roviral therapy at the time of admission. Twenty-
six (24%) patients were started on antiretrovirals 
while admitted on our unit. All but two of the 71 
patients (97%) were on a nucleoside reverse trans- 
criptase inhibitor (NNRTI)-based regimen, along 
with a nucleoside backbone. Of those who started 
antiretrovirals while in hospitals, CD4 counts were 
available for 24 patients. Two of the 24 patients had 
a CD4 count of <200 cells/µL. One patient had a 
CD4 count of 210 cells/µL and a diagnosis of a pul-
monary infection. The second patient had a CD4 
count of 575 cells/µL and was diagnosed with pul-
monary TB. 
DISCUSSION
Most (94%) patients admitted to the Jagori Unit 
were adults. The small number of paediatric admis-
sions hopefully reflects a small number of children 
infected with HIV in Bangladesh but little data ex-
ist on the actual prevalence of paediatric HIV in the 
country. 
Table 2. Opportunistic infections and/or HIV-
related conditions diagnosed in both 
adult and paediatric patients (patients 
may have had more than 1 diagnosis)
Diagnosis
Cases
No. %
Tuberculosis—all
Pulmonary
Disseminated
TB meningitis
Lymph node
Joint
25
16
5
2
1
1
23
Pulmonary infection 12 11
Candidiasis—all
Oral 
Oesophageal
Vulvovaginal
11
3
5
3
10
Pregnancy-related admission 8 7.3
Skin—all
Fungal
Drug rash
Infestation (scabies)
8
4
3
1
7.3
Abscess/cellulitis 6 5.5
CMV disease—all
CMV retinitis
CMV colitis
4
3
1
3.7
Sepsis  5 4.6
Herpes Zoster 3 2.8
Malignancy—all
Kaposi sarcoma
Poorly-differentiated 
carcinoma of tongue
Infantile fibrosarcoma
3
1
1
1
2.8
Peripheral neuropathy 3 2.8
Disseminated histoplasmosis 2 1.8
Cryptosporidiosis 1 0.9
Shigellosis  1 0.9
Bacterial meningitis 1 0.9
Recurrent otitis media 1 0.9
CMV=Cytomegalovirus; HIV=Human immuno- 
deficiency virus; TB=TuberculosisMatin N et al.
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The largest group of patients in our cohort reported 
heterosexual transmission. In 37% of the admis-
sions, a previous history of external migration was 
recorded.
Recent data from our own voluntary counselling 
and testing (VCT) centre within the Jagori Unit of 
ICDDR,B demonstrated that, of the male clients 
who were HIV-positive, over 70% were returning 
migrant workers from overseas. The vast major-
ity travel to the Middle East or other countries 
in South Asia for employment. Mercer et al. re-
ported that extramarital sex was 2-3 times higher 
in spouses who live apart (5). The proportions of 
men who reported sex with a female sex worker 
(51%) or with another male (5.4%) while living 
away were also higher. Subtyping of HIV suggests 
that these infections were acquired from abroad. 
The true prevalence of HIV infection in this client 
group as a whole is unknown, and effective inter-
vention measures to prevent HIV infection among 
returning migrants and their spouses require fur-
ther study.
In our cohort, the second largest group of patients 
had no other recorded risk for HIV transmission 
other than an HIV-positive spouse (29%). This 
group comprised exclusively females. However, 
one cannot ascertain who was infected first—the 
patient or the spouse. The proportion of patients 
with a previous history of injecting drug-use (IDU) 
was 10%. The prevalence data in Bangladesh re-
vealed a concentrated epidemic of HIV among 
IDUs, with prevalence rates up to 7% (1). Lower 
rates of admissions of IDUs may reflect referral 
practices for them or differing healthcare-seeking 
behaviour among this client group. Bisexuality 
or MSM practices were recorded on only two oc- 
casions. Societal attitudes within Bangladesh may 
discourage patients from admitting this to 
healthcare practitioners. Only one patient was 
thought to be infected by a blood transfusion. 
Unsafe blood transfusion is a matter of concern 
in Bangladesh where professional blood donors 
still donate blood to earn extra income. They are 
more likely to be infected with bloodborne virus-
es than voluntary donors, with one report quot-
ing a hepatitis B surface antigen positivity rate 
of 29% vs 4% in voluntary donors (6). National 
blood-screening recommendations are in place 
in Bangladesh but monitoring of blood banks to 
ensure adherence to the recommendations needs 
strengthening.
With respect to CD4 count data, the largest number 
of patients was in the group with CD4 counts of 51-
200 cells/µL (31%). The second largest group had 
CD4 counts of above 350 cells/µL (26%). Although 
those with a CD4 count of <50 cells/µL represent-
ed 24% of the cohort, 62% of deaths were in this 
group of patients, indicating high morbidity and 
mortality associated with low CD4 counts, which 
has been previously reported (7). 
TB was the most frequently-recorded diagnosis and 
the commonest attributable cause of death in our 
series. Worldwide, it is estimated that 8% of new 
TB cases are attributable to HIV infection, and data 
from 2006 showed that 200,000 persons globally 
died from HIV-TB co-infection (8). Despite the ad-
vent of highly-active antiretroviral therapy, TB is 
commonly diagnosed in HIV patients in other case 
series within Asia. Three other case series reflect a 
much higher TB diagnosis rate than we encoun-
tered in our patient-group. A series from Thailand 
reported 42% prevalence of TB (9) while two case 
series from India reported TB infection rates of 
52% and 55% (10,11).
Bangladesh is a high-burden country (387 per 
100,000 population) for TB (12), and so one would 
expect that we would have seen rates of TB preva-
lence closer to those quoted in other studies from 
the region. The lower prevalence in this group 
of admitted patients may possibly reflect a lower 
prevalence in our cohort of patients; however, 
this seems unlikely when one considers the socio-
economic context of Bangladesh, the high preva-
lence of TB in Bangladesh, and also what is already 
known about the epidemiology of HIV-TB co-infec-
tion. We conjecture that it may, in part, reflect the 
steep learning curve for doctors who are trying to 
diagnose TB, which can present atypically in HIV-
infected patients (13-15).
In Bangladesh, chest x-ray and sputum smear mi-
croscopy for acid fast bacilli (AFB) are widely availa-
ble but culture facilities are limited to a handful of 
centres (including our centre). TB in Bangladesh is 
commonly diagnosed by suggestive clinical symp-
toms and signs coupled with a suggestive chest x-
ray and sputum sample that is smear microscopy-
positive for AFB. HIV-positive patients with active 
TB may still have a normal chest x-ray and may 
have sputum specimens that are smear-negative 
for AFB; however, the sputum may subsequently 
be culture-positive. It is important that clinicians 
retain a high index of suspicion for TB, especially 
in patients with suggestive symptoms, despite ini-
tial investigations being normal.
Overall, the prevalence of TB in this patient-group 
we describe here only represents those who were 
ill enough to warrant hospital admission and will, 
thus, represent the tip of the iceberg in terms of 
TB-HIV co-infection in Bangladesh. As the cohort 
of HIV-infected patients grows in Bangladesh and 
the experience of managing these cases increas-
es, we expect to see a proportionate increase in Matin N et al. Clinical profile of HIV/AIDS-infected patients in Bangladesh
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the number of diagnosed TB cases in this patient-
group.
Antiretroviral treatment in Bangladesh is prima-
rily based on non-nucleoside reverse transcriptase 
inhibitor regimes with limited availability of pro-
tease inhibitors (PI). Drugs for the treatment of 
TB are usually supplied by the National TB Pro-
gramme free of charge to the healthcare facility 
but rifabutin is not available through this pro-
gramme if required for a patient on a PI-based 
regime. In common with many other developing 
countries, the limited choice of ARVs and the 
well-described interactions between TB drugs and 
ARVs through the cytochrome P450 system in the 
liver (16) present additional challenges to man-
aging TB-HIV co-infection in this setting. 
Oral or oesophageal candidiasis was only reported 
in eight patients. The mean CD4 count in this group 
was 244, which may explain the lower numbers 
seen, as this tends to present more often with CD4 
counts of <200 cells/µL (17). 
Certain common opportunistic infections are not 
described in this case series. The lack of pneu-
mocystis pneumonia diagnoses may be due to a 
number of reasons. Co-trimoxazole prophylaxis 
against pneumocystis infection is effective (18) and 
widely available and prescribed to patients newly 
diagnosed with HIV presenting with a CD4 count 
of <200 cells/µL. In addition, diagnostic facilities 
to diagnose pneumocystis are at present limited 
in Bangladesh; so, it is possibly being underdiag-
nosed. In the case of fungal infections, two cases 
of disseminated histoplasmosis were diagnosed on 
histological examination of a lymph node biopsy 
and a skin biopsy respectively. There are no cases 
of cryptococcal disease noted. Despite widespread 
reports of penicilliosis in South-East Asia (19) and 
India (20), none was identified in our series. There 
is, at present, limited availability of fungal stains 
and/or culture and cryptococcal antigen tests in 
Bangladesh, which can limit the ability to diagnose 
this group of conditions.
As the experience of managing HIV patients in 
Bangladesh increases, it is hoped that the demand 
for and availability of these tests will increase. Cer-
ebral toxoplasmosis is often diagnosed radiologi-
cally in the context of clinical history and signs. 
No cases were diagnosed in the above cohort. 
No data on the prevalence of toxoplasma infec-
tion in Bangladesh are available, although case 
series from neighbouring India quoted a figure of 
31% in healthy volunteers and a prevalence of 68% 
in HIV-infected patients (21). It is not clear why we 
have not observed any cases of cerebral toxoplas-
mosis, although the widespread use of co-trimoxa-
zole prophylaxis may explain this to some degree. 
Among the diagnoses not associated with HIV, the 
incidence of diabetes mellitus in our case series was 
8.2%, which reflects urban estimates of type 2 dia-
betes in Bangladesh (22). 
Most (92%) patients are known to be HIV-positive 
upon referral to this unit; however, nine (8%) pa-
tients were diagnosed while in the hospitals. Test-
ing of HIV antibody is not routinely carried out 
in all hospitals in Bangladesh, and many hospital 
facilities do not have the laboratory capability to 
carry out HIV testing. Late diagnosis of HIV infec-
tion has been associated with increased mortality 
and morbidity due to HIV (23). Many undiagnosed 
HIV patients with advanced disease may present to 
healthcare facilities on multiple occasions, and the 
diagnosis will be missed (24). As knowledge and 
understanding about HIV becomes more widely 
known, it is hoped that inpatient HIV counselling 
and testing will be more widely available in health-
care settings in Bangladesh. 
Conclusions
Bangladesh is still at the beginning of an evolving 
epidemic of HIV-associated disease. This case series 
serves to describe the spectrum of HIV-associated 
disease and opportunistic infections in Bangladesh 
where currently there is a paucity of data in this 
field. Healthcare providers in Bangladesh are rising 
to the challenge of managing this emerging disease 
in the country but are still at the beginning of the 
learning curve in how to manage HIV. The lack of 
diagnostic facilities in many healthcare facilities in 
Bangladesh poses an additional challenge to those 
wishing to manage opportunistic infections in this 
patient-group. While technical capacity is increased 
to manage this condition nationwide, strong refer-
ral pathways between district health facilities and 
specialist centres must be created and nurtured. Des- 
pite the challenge of dealing with a relatively new 
disease in Bangladesh, the commonest problem we 
encountered was still from M. tuberculosis-associ-
ated infection. It is important to avoid developing 
vertical HIV programmes that do not interact well 
with the pre-existing healthcare infrastructure that 
is in place to control TB in Bangladesh. A good 
link with the national TB-control programmes 
must be maintained to ensure uninterrupted sup-
ply of treatment materials for TB and also to ensure 
minimal interactions with antiretroviral therapy 
for HIV-TB co-infected patients. This link will be an 
important tool in the fight against TB in this 
already-high burden nation. 
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